NCT05573789View on ClinicalTrials.gov

Tumor Molecular Profiling in Patients With Prostate Cancer

CompletedOBSERVATIONAL
Enrollment

220

Participants

Timeline

Start Date

January 1, 2018

Primary Completion Date

December 31, 2020

Study Completion Date

September 1, 2022

Conditions
Prostate CancerMetastatic Prostate Adenocarcinoma
Interventions
GENETIC

Tumor molecular profiling

Tumor molecular profiling was assessed using the ForeSENTIA® Prostate panel developed by NIPD Genetic

Trial Locations (1)

11524

Hellenic Cooperative Oncology Group, Athens

Sponsors

Collaborators (1)

NIPD Genetics
All Listed Sponsors
collaborator

NIPD Genetics

UNKNOWN

lead

Hellenic Cooperative Oncology Group

OTHER